Press Release: New Phase 2b results for amlitelimab support potential for best-in-class maintenance of response in atopic dermatitis

Nitesh sinha March 11, 2024
https://ift.tt/MkUtvnu

New Phase 2b results for amlitelimab support potential for best-in-class maintenance of response in atopic dermatitis



from Sanofi - Aventis Groupe https://ift.tt/9bEQS2N
via IFTTT
Tags:
Nitesh sinha

Posted by: Nitesh sinha

Post a Comment

0 Comments

Please ,
Do not enter any kind of span link